Abstract
Given biotechnology's difficulties in obtaining process patents in the past, does section 103(b) offer the best solution?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pub. Law No. 104-41 (Nov. 1, 1995) (to be codified at 35 U.S.C. §103(b)).
U.S.P.Q.2d 1127 (Fed. Cir. 1995).
Appeal No. 92-1225 (Fed. Cir. Dec. 13, 1995).
The Official Gazette notice on this subject is available on the Web at http://www.uspto.gov/web/uspto/og/ ochiai.html.
763 F.2d 1406,226 U.S.P.Q. 359 (Fed. Cir. 1985).
383 U.S. 1,148 U.S.P.Q. 459 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Horn, C., Barlow, S. The new section 103(b) of the patent law: An obvious solution?. Nat Biotechnol 14, 773–774 (1996). https://doi.org/10.1038/nbt0696-773
Issue Date:
DOI: https://doi.org/10.1038/nbt0696-773